Advances in Clinical Infections and Antimicrobial Resistance
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Antimicrobial Agents and Resistance".
Deadline for manuscript submissions: 28 February 2026
Special Issue Editor
Special Issue Information
Dear Colleagues,
The global rise of multidrug-resistant organisms (MDROs) poses a critical challenge to clinical practice. Driven by complex factors, including antimicrobial uses in humans, animals, and agriculture, international travel, climate change, an aging population, and a growing number of vulnerable individuals, the epidemiology of MDROs is rapidly evolving. This Special Issue on “Clinical Infections and Resistance Development” aims to explore these dynamic changes and advance strategies for the control, diagnosis, and management of MDROs, especially those that could inform and guide clinical practice and public health policy.
We invite submissions that address, but are not limited to, the following areas:
- Epidemiological shifts in MDRO prevalence and their contributing factors.
- Phenotypic and/or molecular characterization of MDRO.
- Innovative workflows or techniques for early MDRO detection and/or control.
- Effective strategies for controlling MDROs in hospital or community settings.
- Clinical management and treatment approaches for MDRO infections.
- Novel therapeutic strategies to combat MDROs.
Dr. Sally Cheuk Ying Wong
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- multidrug resistant organisms
- antimicrobial resistance
- clinical infections
- resistant genes
- antimicrobial stewardship
- infection control
- novel therapies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
